tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with ovalbumin in 1 studies
| Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
|---|---|---|---|---|---|
| 111 | 0 | 29 | 19,565 | 63 | 5,664 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H; Guan, W; Li, G; Liu, Y; Sun, S; Wu, L; Zheng, T | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and ovalbumin
| Article | Year |
|---|---|
Surface topologized ovalbumin scaffolds containing YIGSR peptides for modulating Schwann cell behavior.
Topics: Axons; Humans; Nerve Regeneration; Ovalbumin; Peptides; Peripheral Nerve Injuries; Schwann Cells; Tissue Scaffolds | 2023 |